Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of AG-920 (Articaine) Ophthalmic Solution for Ocular Anesthesia
NCT04513652Phase 3Completed
- Sponsor
- American Genomics
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of articaine in ocular anesthesia, sponsored by American Genomics. Started Sep 2020; status: completed.
02
Drugs
articaine
03
Conditions
ocular anesthesia
Beyond the preview
Go deeper on NCT04513652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04513652.